PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Guangdong Provincial Institute of Biological Products and Materia Medica, Guangzhou, People\'s Republic of China.\', \'National Institutes for Food and Drug Control, Beijing, People\'s Republic of China.\', \'Guangdong Provincial Center for Disease Control and Prevention, Guangzhou, People\'s Republic of China.\', \'Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, People\'s Republic of China.\', \'Gaozhou Center for Disease Control and Prevention, Maoming, People\'s Republic of China.\', \'Key Laboratory of Infection and Immunity, Institute of Biophysics, Chinese Academy of Sciences, Beijing, People\'s Republic of China.\', \'Institute for Hepatology, National Clinical Research Center for Infectious Disease, Shenzhen Third People\'s Hospital, Shenzhen, People\'s Republic of China.\', \'LivzonBio Inc., Zhuhai, People\'s Republic of China.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1080/22221751.2021.1951126
?:doi
?:hasPublicationType
?:journal
  • Emerging microbes & infections
is ?:pmid of
?:pmid
?:pmid
  • 34197281
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Safety and immunogenicity of a recombinant interferon-armed RBD dimer vaccine (V-01) for COVID-19 in healthy adults: a randomized, double-blind, placebo-controlled, Phase I trial.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34197281>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34197281>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all